Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CDKN2A |
Variant | E120* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CDKN2A E120* results in a premature truncation of the Cdkn2a protein at amino acid 120 of 156 (UniProt.org). E120* is predicted to confer a loss of function to the Cdkn2a protein, as demonstrated by a loss of Cdk binding in an in vitro assay (PMID: 8668202). |
Associated Drug Resistance | |
Category Variants Paths |
CDKN2A mutant CDKN2A inact mut CDKN2A E120* |
Transcript | NM_000077.5 |
gDNA | chr9:g.21971001C>A |
cDNA | c.358G>T |
Protein | p.E120* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011517676 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_000077.5 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517675.3 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_001195132.1 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_001195132 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517676.3 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517675 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517676.2 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_000077.4 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_047422598.1 | chr9:g.21970450C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517675.2 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_047422596.1 | chr9:g.21970450C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_000077 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_001195132.2 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|